| ITALY | WP4 | |||
| Organization | University of Verona | |||
| Name of cohort | UNIVR - HIV | |||
| Referring partner | UNIVR | |||
| Cohort Information | Country(-ies), cities, regions or centers involved | Verona, Italy | ||
| Time of data collection | 10/2021 | 05/2023 | ||
| Enrolment | Inactive | |||
| Study setting | Single center | |||
| Population | Age | Adults,Elderly | ||
| Type | Prospective | |||
| Total number of patients | 304 | |||
| Type of frailty (WP4) | HIV | |||
| Data collection | Clinical data | True | ||
| Serological data | True | |||
| Genetic data | False | |||
| Sample collection | True | |||
| Sample collected | Whole blood | No | ||
| PBMC | Yes | |||
| Dry-spot blood | No | |||
| Plasma | Yes | |||
| Serum | No | |||
| Stool | No | |||
| NP swabs | No | |||
| Other | None | |||
| Description | Study of prevalence of SARS-CoV-2 infection in a population of HIV-Ab positive patients evaluation of vaccination outcome in these setting of population socio-economic-sanitary outcome of pandemic in HIV-positive population. LWH adult patients followed up at the dedicated local outpatient clinic and vaccinated against SARS CoV 2. Prospectively followed by the administration of the I / II vaccine's dose onwards. | |||